STS101
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for STS101, covering 2023-06-29 to 2023-07-24. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine [Phase 3]